A noninterventional observational registry of patients with multiple myeloma treated with lenalidomide in Taiwan
The incidence of multiple myeloma in Asia has risen in the past 30 years. Lenalidomide, an IMiD immunomodulatory agent, has improved the overall survival in patients with relapsed/refractory multiple myeloma (RRMM) when used with dexamethasone versus dexamethasone alone. This observational registry...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier
2017-09-01
|
| Seri Bilgileri: | Journal of the Formosan Medical Association |
| Konular: | |
| Online Erişim: | http://www.sciencedirect.com/science/article/pii/S092966461630393X |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|